Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Drugs like PDEI may help hair disorders like AGA.

Carthamus oxyacantha may help treat BPH by inhibiting 5α-reductase.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

JAK inhibitors show promise in treating difficult skin diseases.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

The rash resolved after stopping ponatinib.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

A natural steroid in the body may protect against eye damage in glaucoma.

Finasteride effectively prevents hair loss and promotes hair growth in men with androgenetic alopecia.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Baricitinib may not always prevent relapse in alopecia areata.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.